Ocular Therapeutix Statistics
Total Valuation
OCUL has a market cap or net worth of $1.13 billion. The enterprise value is $814.33 million.
Important Dates
The next estimated earnings date is Tuesday, May 6, 2025, after market close.
| Earnings Date | May 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
OCUL has 159.02 million shares outstanding. The number of shares has increased by 84.90% in one year.
| Current Share Class | 159.02M |
| Shares Outstanding | 159.02M |
| Shares Change (YoY) | +84.90% |
| Shares Change (QoQ) | +0.61% |
| Owned by Insiders (%) | 0.78% |
| Owned by Institutions (%) | 63.36% |
| Float | 124.12M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 17.66 |
| Forward PS | 16.00 |
| PB Ratio | 3.56 |
| P/TBV Ratio | 3.59 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 12.78 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.66, with a Debt / Equity ratio of 0.24.
| Current Ratio | 10.66 |
| Quick Ratio | 10.27 |
| Debt / Equity | 0.24 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -12.77 |
Financial Efficiency
Return on equity (ROE) is -95.21% and return on invested capital (ROIC) is -38.31%.
| Return on Equity (ROE) | -95.21% |
| Return on Assets (ROA) | -30.53% |
| Return on Invested Capital (ROIC) | -38.31% |
| Return on Capital Employed (ROCE) | -41.62% |
| Revenue Per Employee | $232,566 |
| Profits Per Employee | -$706,226 |
| Employee Count | 274 |
| Asset Turnover | 0.18 |
| Inventory Turnover | 49.86 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -10.11% in the last 52 weeks. The beta is 1.49, so OCUL's price volatility has been higher than the market average.
| Beta (5Y) | 1.49 |
| 52-Week Price Change | -10.11% |
| 50-Day Moving Average | 7.30 |
| 200-Day Moving Average | 8.47 |
| Relative Strength Index (RSI) | 49.94 |
| Average Volume (20 Days) | 1,844,228 |
Short Selling Information
The latest short interest is 12.59 million, so 7.92% of the outstanding shares have been sold short.
| Short Interest | 12.59M |
| Short Previous Month | 12.83M |
| Short % of Shares Out | 7.92% |
| Short % of Float | 10.14% |
| Short Ratio (days to cover) | 8.44 |
Income Statement
In the last 12 months, OCUL had revenue of $63.72 million and -$193.51 million in losses. Loss per share was -$1.22.
| Revenue | 63.72M |
| Gross Profit | -69.54M |
| Operating Income | -173.38M |
| Pretax Income | -138.36M |
| Net Income | -193.51M |
| EBITDA | -169.60M |
| EBIT | -173.38M |
| Loss Per Share | -$1.22 |
Full Income StatementBalance Sheet
The company has $392.10 million in cash and $75.78 million in debt, giving a net cash position of $316.32 million or $1.99 per share.
| Cash & Cash Equivalents | 392.10M |
| Total Debt | 75.78M |
| Net Cash | 316.32M |
| Net Cash Per Share | $1.99 |
| Equity (Book Value) | 315.34M |
| Book Value Per Share | 2.00 |
| Working Capital | 399.63M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$134.68 million and capital expenditures -$1.29 million, giving a free cash flow of -$135.97 million.
| Operating Cash Flow | -134.68M |
| Capital Expenditures | -1.29M |
| Free Cash Flow | -135.97M |
| FCF Per Share | -$0.86 |
Full Cash Flow StatementMargins
| Gross Margin | -109.13% |
| Operating Margin | -272.09% |
| Pretax Margin | -303.67% |
| Profit Margin | n/a |
| EBITDA Margin | -266.14% |
| EBIT Margin | -272.09% |
| FCF Margin | n/a |
Dividends & Yields
OCUL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -84.90% |
| Shareholder Yield | -84.90% |
| Earnings Yield | -17.11% |
| FCF Yield | -12.03% |
Analyst Forecast
The average price target for OCUL is $16.22, which is 128.13% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $16.22 |
| Price Target Difference | 128.13% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (5Y) | 61.42% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
OCUL has an Altman Z-Score of 2.09 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.09 |
| Piotroski F-Score | 3 |